title: Notch signaling in prostate cancer: a moving target.
abstract: BACKGROUND
  By regulating cell fate, proliferation, and survival, Notch pathway signaling provides critical input into differentiation, organization, and function of multiple tissues. Notch signaling is also becoming an increasingly recognized feature in malignancy, including prostate cancer, where it may play oncogenic or tumor suppressive roles.
  
  
  METHODS
  Based on an electronic literature search from 2000 to 2013 we identified, summarized, and integrated published research on Notch signaling dynamics in prostate homeostasis and prostate cancer.
  
  
  RESULTS
  In benign prostate, Notch controls the differentiation state and architecture of the gland. In prostate cancer, similar features correlate with lethal potential and may be influenced by Notch. Increased Notch1 can confer a survival advantage on prostate cancer cells, and levels of Notch family members, such as Jagged2, Notch3, and Hes6 increase with higher cancer grade. However, Notch signaling can also antagonize growth and survival of both benign and malignant prostate cells, possibly through antagonistic effects of the Notch target HEY1 on androgen receptor function.
  
  
  CONCLUSIONS
  Notch signaling can dramatically influence prostate development and disease. Determining the cellular contexts where Notch promotes or suppresses prostate growth could open opportunities for diagnostic and therapeutic interventions.
authors.affiliation: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors.forename: Filipe L F
authors.initials: FL
authors.lastname: Carvalho
authors.forename: Brian W
authors.initials: BW
authors.lastname: Simons
authors.forename: Charles G
authors.initials: CG
authors.lastname: Eberhart
authors.forename: David M
authors.initials: DM
authors.lastname: Berman
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000502:physiology; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000473:pathology; D051880:Receptors, Notch / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D051880:Receptors, Notch
keywords: Notch pathway; active surveillance; prostate cancer; targeted therapy; tumor progression
references.citation: Nature. 2004 Nov 18;432(7015):324-31
references.pmid: 15549094
references.citation: Nature. 2011 Jun 29;474(7353):609-15
references.pmid: 21720365
references.citation: Oncogene. 2011 Sep 29;30(39):4075-86
references.pmid: 21499308
references.citation: Dev Biol. 2005 Dec 15;288(2):334-47
references.pmid: 16324690
references.citation: Dev Cell. 2005 Nov;9(5):617-28
references.pmid: 16256737
references.citation: Nature. 2006 Dec 21;444(7122):1083-7
references.pmid: 17183323
references.citation: Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10991-6
references.pmid: 16829574
references.citation: J Clin Oncol. 2009 Sep 10;27(26):4300-5
references.pmid: 19636023
references.citation: Clin Cancer Res. 2010 Jun 15;16(12):3141-52
references.pmid: 20530696
references.citation: Cancer Cell. 2012 Feb 14;21(2):253-65
references.pmid: 22340597
references.citation: Dev Biol. 2011 Dec 15;360(2):329-42
references.pmid: 22015718
references.citation: J Pathol. 2011 Oct;225(2):181-8
references.pmid: 21898876
references.citation: J Invest Dermatol. 1999 Jun;112(6):971-6
references.pmid: 10383747
references.citation: J Biol Chem. 2004 Mar 26;279(13):12876-82
references.pmid: 14709552
references.citation: Oncogene. 1999 Oct 28;18(44):5973-81
references.pmid: 10557086
references.citation: Semin Cancer Biol. 2004 Oct;14(5):341-7
references.pmid: 15288259
references.citation: Mol Cell. 2004 Nov 19;16(4):509-20
references.pmid: 15546612
references.citation: J Exp Med. 1996 May 1;183(5):2283-91
references.pmid: 8642337
references.citation: Science. 2004 Oct 8;306(5694):269-71
references.pmid: 15472075
references.citation: Int J Cancer. 2006 Nov 1;119(9):2071-7
references.pmid: 16823852
references.citation: Nat Genet. 2007 Jan;39(1):41-51
references.pmid: 17173048
references.citation: Dev Biol. 2006 Feb 1;290(1):66-80
references.pmid: 16360140
references.citation: J Clin Invest. 2008 Jan;118(1):217-28
references.pmid: 18079963
references.citation: Cancer Res. 2004 Oct 1;64(19):6854-7
references.pmid: 15466172
references.citation: Clin Cancer Res. 2006 May 15;12(10):3043-9
references.pmid: 16707600
references.citation: Nature. 2009 Sep 24;461(7263):495-500
references.pmid: 19741607
references.citation: Nat Med. 2009 Jan;15(1):50-8
references.pmid: 19098907
references.citation: Nature. 2001 May 17;411(6835):349-54
references.pmid: 11357142
references.citation: Differentiation. 2001 Oct;68(4-5):270-9
references.pmid: 11776479
references.citation: Genes Cancer. 2011 Oct;2(10):956-78
references.pmid: 22701762
references.citation: Urol Clin North Am. 2001 Aug;28(3):555-65
references.pmid: 11590814
references.citation: Hum Mol Genet. 1992 Oct;1(7):497-503
references.pmid: 1307250
references.citation: Nature. 2009 Nov 12;462(7270):182-8
references.pmid: 19907488
references.citation: Cancer Cell. 2011 Feb 15;19(2):192-205
references.pmid: 21295524
references.citation: J Biol Chem. 2004 Jun 4;279(23):24733-44
references.pmid: 15028713
references.citation: Clin Cancer Res. 2009 Jan 15;15(2):452-9
references.pmid: 19147749
references.citation: Anat Rec. 1980 Mar;196(3):263-73
references.pmid: 7406220
references.citation: Dev Biol. 2004 Sep 15;273(2):175-84
references.pmid: 15328005
references.citation: Oncogene. 2004 Dec 16;23(58):9401-7
references.pmid: 15531924
references.citation: Science. 2011 Aug 26;333(6046):1154-7
references.pmid: 21798897
references.citation: Br J Cancer. 2009 Jun 16;100(12):1879-88
references.pmid: 19513078
references.citation: J Biol Chem. 2001 Apr 6;276(14):11204-13
references.pmid: 11063747
references.citation: Endocrinology. 2009 Jan;150(1):463-72
references.pmid: 18801907
references.citation: Nature. 1999 Apr 8;398(6727):518-22
references.pmid: 10206645
references.citation: Cancer Res. 2008 Jul 1;68(13):5226-35
references.pmid: 18593923
references.citation: Cell. 1991 Aug 23;66(4):649-61
references.pmid: 1831692
references.citation: J Clin Oncol. 2012 Jul 1;30(19):2307-13
references.pmid: 22547604
references.citation: J Pathol. 2011 Oct;225(2):172-80
references.pmid: 21898875
references.citation: J Clin Oncol. 2012 Jul 1;30(19):2348-53
references.pmid: 22529266
references.citation: Oncogene. 2010 Apr 29;29(17):2488-98
references.pmid: 20154720
references.citation: Cell Immunol. 1993 Jun;149(1):99-106
references.pmid: 8513514
references.citation: Science. 2007 Feb 16;315(5814):988-92
references.pmid: 17303754
references.citation: Nat Med. 2011 Nov 20;17(12):1646-51
references.pmid: 22101766
references.citation: Br J Cancer. 2011 Sep 6;105(6):796-806
references.pmid: 21847123
references.citation: J Natl Cancer Inst. 2000 Aug 16;92(16):1355-7
references.pmid: 10944559
references.citation: J Urol. 1994 May;151(5):1427-32
references.pmid: 8158800
references.citation: Nat Cell Biol. 2012 Nov;14(11):1131-8
references.pmid: 23064263
references.citation: Curr Top Dev Biol. 2010;92:1-29
references.pmid: 20816391
references.citation: Cancer Cell. 2011 May 17;19(5):575-86
references.pmid: 21575859
references.citation: Cancer Res. 2013 Jun 15;73(12):3489-93
references.pmid: 23740771
references.citation: Clin Cancer Res. 2009 Aug 1;15(15):4799-805
references.pmid: 19638457
references.citation: Anat Rec. 1973 Jan;175(1):87-96
references.pmid: 4734188
references.citation: Immunity. 1999 May;10(5):547-58
references.pmid: 10367900
references.citation: Hum Mol Genet. 2002 Oct 1;11(21):2615-24
references.pmid: 12354787
references.citation: BJU Int. 2009 Jun;103(12):1647-54
references.pmid: 19154461
references.citation: Clin Cancer Res. 2011 Oct 15;17(20):6563-73
references.pmid: 21878536
references.citation: Am J Pathol. 2006 Mar;168(3):973-90
references.pmid: 16507912
references.citation: J Neurosci. 2006 Oct 25;26(43):11061-71
references.pmid: 17065448
references.citation: Nature. 2006 Dec 21;444(7122):1032-7
references.pmid: 17183313
references.citation: Cancer Res. 1999 Jun 1;59(11):2551-6
references.pmid: 10363971
references.citation: Science. 1999 Apr 30;284(5415):770-6
references.pmid: 10221902
references.citation: Cancer Cell. 2009 Jul 7;16(1):55-66
references.pmid: 19573812
references.citation: Cancer Biol Ther. 2010 Nov 15;10(10):994-6
references.pmid: 21057206
references.citation: Cell Stem Cell. 2012 Nov 2;11(5):676-88
references.pmid: 23122291
references.citation: Genes Dev. 2010 Sep 15;24(18):1967-2000
references.pmid: 20844012
references.citation: Nature. 2001 Nov 1;414(6859):105-11
references.pmid: 11689955
references.citation: J Clin Oncol. 2010 Sep 1;28(25):4006-12
references.pmid: 20498387
references.citation: Cancer Cell. 2003 Sep;4(3):209-21
references.pmid: 14522255
references.citation: Oncogene. 2008 Aug 28;27(37):5019-32
references.pmid: 18469855
references.citation: Dis Model Mech. 2013 Mar;6(2):530-6
references.pmid: 23136397
references.citation: Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3534-9
references.pmid: 20133585
references.citation: J Virol. 1987 Jan;61(1):66-74
references.pmid: 3023708
references.citation: J Urol. 2011 Dec;186(6):2221-7
references.pmid: 22014803
references.citation: Nature. 2010 Apr 15;464(7291):1052-7
references.pmid: 20393564
references.citation: Biochim Biophys Acta. 2012 Jun;1822(6):988-95
references.pmid: 22353464
references.citation: Cancer Res. 2010 Nov 15;70(22):8973-6
references.pmid: 21045140
references.citation: Cancer Res. 2007 Jul 15;67(14):6825-43
references.pmid: 17638894
references.citation: Mol Cell Biol. 2005 Feb;25(4):1425-36
references.pmid: 15684393
references.citation: Cancer Res. 1999 Sep 1;59(17):4291-6
references.pmid: 10485474
references.citation: Cancer Res. 2006 Jun 15;66(12):6312-8
references.pmid: 16778208
references.citation: Nature. 2008 Dec 11;456(7223):804-8
references.pmid: 18946470
references.citation: Eur Urol. 2008 Dec;54(6):1344-53
references.pmid: 18375047
references.citation: J Cell Sci. 2013 May 15;126(Pt 10):2135-40
references.pmid: 23729744
references.citation: Oncogene. 2008 Oct 16;27(47):6120-30
references.pmid: 18591932
references.citation: Nature. 2005 Jun 16;435(7044):959-63
references.pmid: 15959515
references.citation: Annu Rev Neurosci. 2002;25:471-90
references.pmid: 12052917
references.citation: Cancer Res. 2007 Sep 1;67(17):8051-7
references.pmid: 17804716
references.citation: Mol Cancer Ther. 2010 Jun;9(6):1618-28
references.pmid: 20530712
references.citation: Cancer Res. 2005 Oct 15;65(20):9269-79
references.pmid: 16230388
references.citation: Prostate. 2011 Oct 1;71(14):1568-77
references.pmid: 21360566
references.citation: Genes Dev. 2010 Mar 15;24(6):590-601
references.pmid: 20231316
references.citation: Cancer Res. 2001 Oct 1;61(19):7291-7
references.pmid: 11585768
references.citation: J Cell Biochem. 2009 Aug 1;107(5):992-1001
references.pmid: 19479935
references.citation: Cancer Res. 2005 Sep 15;65(18):8530-7
references.pmid: 16166334